Lupin inches up on launching Doxercalciferol Injection

19 Dec 2019 Evaluate

Lupin is currently trading at Rs. 772.00, up by 5.90 points or 0.77% from its previous closing of Rs. 766.10 on the BSE.

The scrip opened at Rs. 756.10 and has touched a high and low of Rs. 774.75 and Rs. 756.10 respectively. So far 41712 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 887.70 on 04-Feb-2019 and a 52 week low of Rs. 646.20 on 07-Oct-2019.

Last one week high and low of the scrip stood at Rs. 774.75 and Rs. 745.30 respectively. The current market cap of the company is Rs. 34788.26 crore.

The promoters holding in the company stood at 46.96%, while Institutions and Non-Institutions held 38.99% and 14.05% respectively.

Lupin has launched Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vials, having received an approval from the United States Food and Drug Administration (USFDA) earlier.

The company’s Doxercalciferol Injection, is the therapeutic generic equivalent of Sanofi Genzyme’s Hectorol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials. It is indicated for the treatment of secondary hyperparathyroidism in adult patients with CKD on dialysis. Doxercalciferol Injection (RLD: Hectorol) had an annual sales of approximately $132 million in the U.S. (IQVIA MAT October 2019). 

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

1709.00 -3.05 (-0.18%)
23-May-2024 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1514.35
Dr. Reddys Lab 5900.00
Cipla 1485.00
Zydus Lifesciences 1089.90
Lupin 1709.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.